Relative risk
Relative risk (RR), also known as risk ratio, is a statistical term that is used in epidemiology to quantify the risk of a certain event happening in one group compared to the risk of the same event happening in another group. It is a measure of risk that compares the risk in two different groups of people.
Definition[edit]
Relative risk is defined as the ratio of the probability of an event occurring in an exposed group to the probability of the event occurring in a comparison, non-exposed group. It is used in medical research to determine if an exposure is a risk factor for a particular disease or condition.
Calculation[edit]
The calculation of relative risk involves dividing the probability of the event occurring in the exposed group by the probability of the event occurring in the non-exposed group. This can be represented mathematically as:
RR = (Incidence in Exposed Group) / (Incidence in Non-Exposed Group)
Interpretation[edit]
A relative risk of 1 indicates no difference in risk between the two groups. A relative risk greater than 1 indicates an increased risk of the event in the exposed group. A relative risk less than 1 indicates a decreased risk of the event in the exposed group.
Uses[edit]
Relative risk is used in epidemiological studies, such as cohort studies and case-control studies, to identify and quantify the relationship between exposure and outcome. It is also used in public health to determine the impact of a specific risk factor on a population.
Limitations[edit]
While relative risk is a useful measure in epidemiology, it has several limitations. It does not take into account the baseline risk of the event, and it can be influenced by confounding factors. Additionally, it does not provide information about the absolute risk or the actual difference in risk between the two groups.
See also[edit]
- Relative_risk
-
Illustration of risk reduction
-
Risk Ratio vs Odds Ratio
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
